MUDr. Viera Sandecká, Ph.D.
Assistant professor, Department of Internal Medicine, Hematology and Oncology
phone: | +420 532 23 3881, 3603 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 103
2014
-
Genome-Wide Screening of Cytogenetic Abnormalities in Multiple Myeloma Patients Using Array-CGH Technique: A Czech Multicenter Experience
BioMed Research International, year: 2014, volume: Neuveden, edition: MAY, DOI
2013
-
10 years of experience with thalidomide in multiple myeloma patients: Report of the Czech Myeloma Group
Leukemia Research, year: 2013, volume: 37, edition: 9, DOI
-
Gain(1)(q21) is an Unfavorable Genetic Prognostic Factor for Patients With Relapsed Multiple Myeloma Treated With Thalidomide but Not for Those Treated With Bortezomib
Clinical lymphoma, myeloma & leukemia, year: 2013, volume: 13, edition: 2, DOI
-
Multiple Myeloma Associated Necrobiotic Xanthogranuloma: Treatment Response Monitoring by Means of PET/CT Imaging
Year: 2013, type: Conference abstract
-
První zkušenosti s metodou aCGH u 19 jedinců s monoklonální gamapatií nejasného významu
Year: 2013, type: Conference abstract
2012
-
Analýza moderních prognostických faktorů na buněčné a molekulární úrovni určujících riziko transformace monoklonální gamapatie nejasného významu do mnohočetného myelomu
Klinická biochemie a metabolismus, year: 2012, volume: 20(41), edition: 2
-
Efektivita protokolu FLAMSA-RIC s následnou alogenní transplantací u 60 pacientů s rizikovou AML
Year: 2012, type: Conference abstract
-
Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma - Phase II study results
Neoplasma, year: 2012, volume: 59, edition: 4, DOI
-
Flow cytometry as a predictive tool for transpormation of MGUS into MM
Year: 2012, type: Conference abstract
-
Identification of prognostic factors for malignant transformation in persons with monoclonal gammopathy of undetermined siificance observed in the Czech Republic
Year: 2012, type: Conference abstract